OCT 12, 2021 3:00 PM PDT

Atopic Dermatitis: A Harbinger of Autoimmune Diseases?

WRITTEN BY: Alexandria Bass

New research published in Allergy, Asthma & Clinical Immunology found an increased risk of autoimmune disease development in patients with atopic dermatitis.

Results come from a systematic review and meta-analysis consisting of 14 observational studies, pooling odd ratios (OR) using a random effects model. Patients with atopic dermatitis were found to have a higher prevalence of the following autoimmune diseases: alopecia areata (OR of 9.72), celiac disease (OR of 1.98), Crohn's disease (OR of 1.66), rheumatoid arthritis (OR of 1.18), systemic lupus erythematosus (OR of 1.74), ulcerative colitis (OR of 1.95), and vitiligo (OR of 4.52).

Atopic dermatitis, the most common chronic inflammatory skin disease, is estimated to affect at least 230 million people across the globe. Symptoms usually start early in life and include the formation itchy lesions. Suspected causes include reduced epidermal barrier function, dysregulation of the immune system, and/or altered microbiome. 

In some cases of atopic dermatitis, reduced epidermal barrier function was traced back to reductions in or the complete absence of the protein filaggrin required for normal epidermal structure. This change in structure leads to increased transepidermal water loss in patients with atopic dermatitis. These disruptions in skin barrier function have been found to cause a strong Th2 inflammatory response, a process of the adaptive immune system. Th2 responses drive antibody and eosinophil production. The connection between atopic dermatitis and autoimmunity could be related to similar changes in adaptive immune function. 

Genetic variants associated with atopic dermatitis may also be associated with specific autoimmune diseases. Researchers in this study noted that in a recent meta-analysis of genome-wide association studies, 10 new susceptibility loci for atopic dermatitis overlapped with those associated with multiple autoimmune diseases.

Reported study limitations included small sample sizes for some of the studies included in the meta-analysis, inconsistency between the studies in terms of which confounding factors they controlled for, and the use of subjective questionnaires in some studies to assess atopic dermatitis and autoimmune disorders.
 

About the Author
  • Alexandria (Alex) is a freelance science writer with a passion for educating the public on health issues. Her other professional experience includes working as a speech-language pathologist in health care, a research assistant in a food science laboratory, and an English teaching assistant in Spain. In her spare time, Alex enjoys cycling, lap swimming, jogging, and reading.
You May Also Like
JAN 13, 2022
Cardiology
Extreme Exercise and Heart Disease Risk
JAN 13, 2022
Extreme Exercise and Heart Disease Risk
Marathons and HIIT workouts are more popular than ever. But how do they impact the heart?
JAN 12, 2022
Health & Medicine
Should You Intentionally Get Omicron?
JAN 12, 2022
Should You Intentionally Get Omicron?
With the pandemic coming up on its 2-year anniversary, the ironic question more people are contemplating with this less ...
JAN 16, 2022
Plants & Animals
Consuming More Olive Oil Lowers Risk of Cardiovascular Disease Mortality
JAN 16, 2022
Consuming More Olive Oil Lowers Risk of Cardiovascular Disease Mortality
It’s estimated that olive oil has been manufactured by humans for nearly 6,000 years. When it was first produced, ...
JAN 17, 2022
Microbiology
Research Suggests Epstein Barr Virus Can Cause Multiple Sclerosis
JAN 17, 2022
Research Suggests Epstein Barr Virus Can Cause Multiple Sclerosis
Multiple sclerosis (MS) is a chronic autoimmune disease that impacts nearly 3 million people around the world. The cause ...
JAN 18, 2022
Drug Discovery & Development
Identifying Oncostatin M (OSM): One Protein's Role in Severe Asthma
JAN 18, 2022
Identifying Oncostatin M (OSM): One Protein's Role in Severe Asthma
Asthma is a chronic condition that is characterized by difficulty breathing, coughing, and wheezing which is caused, in ...
JAN 20, 2022
Drug Discovery & Development
Review Finds Improved Transparency Among Antidepressant Drug Trials
JAN 20, 2022
Review Finds Improved Transparency Among Antidepressant Drug Trials
Trials relating to newly developed antidepressant drugs are becoming more transparent. The corresponding study was publi ...
Loading Comments...